IR thematic call on Diabetes

Sanofi hosted a Thematic Call on Diabetes for the financial community in connection with the American Diabetes Association's Scientific Sessions.

• Presentation

• June 8, 2015: Sanofi's Lyxumia® (lixisenatide) Demonstrated Cardiovascular Safety in People with Type 2 Diabetes and High CV Risk
• June 6, 2015: Sanofi Announces Positive Results for Toujeo® in Phase III Study Extension in Japanese People with Uncontrolled Diabetes